Literature DB >> 10594623

Prolonged clinical and histologic effects from CO2 laser resurfacing of atrophic acne scars.

S Walia1, T S Alster.   

Abstract

BACKGROUND: The recent development of high-energy pulsed CO2 lasers that minimize thermal injury to uninvolved adjacent structures has revolutionized the manner in which atrophic facial scars are recontoured. Significant improvement of atrophic scars with laser resurfacing has clearly been demonstrated; however, the exact timing for assessment of skin for further treatment has varied due to the unknown amount of time needed after laser scar resurfacing to effect maximal collagen formation and remodeling.
OBJECTIVE: The aim of this study was to determine the immediate and long-term (12-18 months) histologic and clinical effects of atrophic acne scars after CO2 laser resurfacing in order to provide physician guidelines for postoperative clinical assessment for retreatment.
METHODS: Sixty patients (50 women, 10 men, mean age 38 years, skin types I-V) with moderate to severe atrophic facial scars were evaluated. Nineteen patients received regional cheek treatment and 41 patients received full-face resurfacing with a high-energy pulsed CO2 laser. Independent clinical assessments of treated scars were performed at 1, 6, 12, and 18 months and blinded histologic analyses were made of skin biopsies immediately prior to and after laser resurfacing, and at 1, 6, 12, and 18 months postoperatively in six patients.
RESULTS: Significant immediate and prolonged clinical improvement in skin tone, texture, and appearance of CO2 laser-irradiated scars was seen in all patients. Average clinical improvement scores were 2.22 (69%) at 1 month, 2.1 (67%) at 6 months, 2.37 (73%) at 12 months, and 2.5 (75%) at 18 months. Continued collagenesis and subsequent dermal remodeling were observed on histologic examination of biopsied tissue up to 18 months after surgery.
CONCLUSION: Continued clinical improvement was observed as long as 18 months after CO2 laser resurfacing of atrophic scars, with an 11% increase in improvement observed between 6 and 18 months postoperatively. We propose that a longer postoperative interval (12-18 months) prior to assessment for re-treatment be advocated in order to permit optimal tissue recovery and an opportunity for collagen remodeling.

Entities:  

Mesh:

Year:  1999        PMID: 10594623     DOI: 10.1046/j.1524-4725.1999.99115.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  8 in total

1.  Laser resurfacing pearls.

Authors:  Sonia Shah; Murad Alam
Journal:  Semin Plast Surg       Date:  2012-08       Impact factor: 2.314

2.  A new modality for fractional CO2 laser resurfacing for acne scars in Asians.

Authors:  Luping Huang
Journal:  Lasers Med Sci       Date:  2012-05-22       Impact factor: 3.161

Review 3.  Acne Scarring-Pathogenesis, Evaluation, and Treatment Options.

Authors:  Deirdre Connolly; Ha Linh Vu; Kavita Mariwalla; Nazanin Saedi
Journal:  J Clin Aesthet Dermatol       Date:  2017-09-01

4.  Fractional CO2 laser as an effective modality in treatment of striae alba in skin types III and IV.

Authors:  Farahnaz Fatemi Naein; Mehrnaz Soghrati
Journal:  J Res Med Sci       Date:  2012-10       Impact factor: 1.852

Review 5.  Evaluating evidence for atrophic scarring treatment modalities.

Authors:  Lopa Patel; Duncan McGrouther; Kaushik Chakrabarty
Journal:  JRSM Open       Date:  2014-08-11

Review 6.  The role of lasers and intense pulsed light technology in dermatology.

Authors:  Zain Husain; Tina S Alster
Journal:  Clin Cosmet Investig Dermatol       Date:  2016-02-04

7.  Plasma Radiofrequency Ablation for Scar Treatment.

Authors:  Adone Baroni; Pasquale Verolino
Journal:  J Clin Med       Date:  2021-12-27       Impact factor: 4.241

8.  Treatment of mesh skin grafted scars using a plasma skin regeneration system.

Authors:  Takamitsu Higashimori; Taro Kono; Hiroyuki Sakurai; Hiroaki Nakazawa; William Frederick Groff
Journal:  Plast Surg Int       Date:  2010-07-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.